More Hemlibra Deaths

Updated: Jul 22, 2020

Genentech released the quarterly fatalities report for Emicizumab (Hemlibra) and there are now 34 reported deaths. This makes it the most reported deaths for a Hemophilia product since FDA approval.

HemoAware has been the only organization to report this news to the community since it's entry into the market.


Recent Posts

See All